Key Points
Xylem beat EPS by 2.75% and revenue by 0.72% in Q2 2026
Stock declined 2.13% post-earnings despite positive results
Meyka AI rates XYL with B+ grade reflecting neutral positioning
Operating cash flow and free cash flow declined year-over-year
Xylem Inc. (XYL) delivered a solid earnings beat on April 28, 2026, exceeding both EPS and revenue expectations. The water infrastructure and industrial machinery company reported earnings per share of $1.12, surpassing the $1.09 estimate by 2.75%. Revenue came in at $2.12 billion, beating the $2.11 billion forecast by 0.72%. The results demonstrate consistent operational execution across Xylem’s three business segments. However, the stock declined 2.13% following the announcement, reflecting broader market pressures. Meyka AI rates XYL with a grade of B+, indicating neutral positioning with mixed fundamental signals.
Xylem Earnings Beat Expectations
Xylem delivered better-than-expected results in its latest earnings report, showing strength across key metrics. The company beat EPS estimates by 2.75% and revenue estimates by 0.72%, demonstrating solid operational performance.
EPS Performance
Xylem reported diluted EPS of $1.12 against the consensus estimate of $1.09. This represents a 2.75% beat, indicating stronger profitability than anticipated. The company’s net income growth of 7.53% year-over-year supports this positive result. Compared to the previous quarter’s EPS of $1.42, this quarter shows a sequential decline, though that prior quarter benefited from higher seasonal demand.
Revenue Achievement
Total revenue reached $2.125 billion, exceeding the $2.109 billion estimate by $16 million or 0.72%. This marks the fourth consecutive quarter of revenue beats for Xylem. The company’s revenue growth of 5.52% year-over-year reflects steady demand across its water infrastructure, applied water, and measurement solutions segments. Gross profit margin expanded to 38.61%, up from prior year levels, showing improved operational efficiency.
Quarterly Performance Comparison
Xylem’s latest results fit into a pattern of consistent execution, though this quarter shows mixed performance relative to recent quarters. Understanding the trend helps investors assess the company’s trajectory.
Sequential Quarter Trends
The current quarter’s EPS of $1.12 represents a decline from the prior quarter’s $1.42, but this is typical given seasonal patterns in water infrastructure spending. However, it exceeds the quarter from two periods ago ($1.26) and the quarter from three periods ago ($1.03). Revenue of $2.125 billion is lower than the prior quarter’s $2.397 billion but higher than the average of the previous three quarters. This suggests normal seasonal variation rather than operational deterioration.
Beat Consistency
Xylem has now beaten EPS estimates in three of the last four quarters, with the February quarter matching estimates exactly. Revenue beats have occurred in all four recent quarters, demonstrating management’s ability to forecast accurately and execute reliably. This consistency builds investor confidence in the company’s operational discipline and market positioning.
Market Reaction and Stock Movement
Despite beating earnings expectations, Xylem’s stock declined following the announcement, reflecting broader market dynamics and valuation concerns. The market’s reaction provides context for understanding investor sentiment.
Post-Earnings Decline
Xylem shares fell 2.13% on the earnings announcement, closing at $115.40 from the prior close of $117.91. This decline occurred despite positive earnings results, suggesting the market may have already priced in the beat or faced profit-taking after the stock’s recent weakness. The stock has declined 2.13% over the past day and 4.58% over the past five days, indicating broader selling pressure.
Valuation Context
The stock trades at a PE ratio of 28.71, which is elevated relative to historical averages and the broader market. With a price-to-sales ratio of 3.04 and price-to-book ratio of 2.54, Xylem commands a premium valuation. The market may be concerned about growth sustainability at current valuations, particularly given the modest revenue beat of just 0.72%. Analyst consensus remains bullish with 12 buy ratings versus 5 holds.
Meyka AI Grade and Forward Outlook
Xylem receives a B+ grade from Meyka AI, reflecting a balanced assessment of the company’s fundamentals and growth prospects. The rating suggests neutral positioning with both strengths and concerns.
Grade Breakdown
Meyka AI’s B+ rating incorporates multiple factors including financial growth (12%), key metrics (16%), sector comparison (16%), analyst consensus (14%), and forecasts (8%). The company scores strongly on return on assets (5/5 Strong Buy) and DCF valuation (4/5 Buy), but faces headwinds on debt-to-equity (2/5 Sell) and PE valuation (2/5 Sell). This mixed profile explains the neutral recommendation despite solid earnings execution.
Growth Trajectory
Xylem’s five-year revenue growth per share stands at 37.12%, while three-year growth reaches 21.15%. Net income per share has grown 178.81% over five years, demonstrating strong profitability expansion. However, operating cash flow declined 1.74% year-over-year, and free cash flow fell 3.40%, raising questions about cash generation sustainability. The company maintains a healthy current ratio of 1.46 and manageable debt-to-equity of 0.18, providing financial flexibility for strategic investments.
Final Thoughts
Xylem Inc. beat Q2 2026 earnings expectations with 2.75% EPS growth and 0.72% revenue growth, demonstrating solid operational execution. Revenue reached $2.125 billion and EPS hit $1.12. Despite strong fundamentals, the stock fell 2.13% post-earnings due to investor concerns about its 28.71 PE ratio and slowing growth. Meyka AI’s B+ rating reflects this tension: strong cash generation offset by elevated valuations. Long-term investors should note the earnings beat validates management, but near-term momentum faces headwinds from premium pricing and market pressures.
FAQs
Did Xylem beat or miss earnings estimates?
Xylem beat both estimates. EPS came in at $1.12 versus $1.09 expected, a 2.75% beat. Revenue reached $2.125 billion versus $2.109 billion forecast, a 0.72% beat. This marks the third consecutive quarter of EPS beats.
How does this quarter compare to previous quarters?
Current EPS of $1.12 is lower than the prior quarter’s $1.42 but higher than two quarters ago ($1.26). Revenue of $2.125 billion is below the prior quarter but above the three-quarter average. Seasonal variation explains most differences, with consistent beat patterns.
Why did the stock decline after beating earnings?
XYL fell 2.13% despite the beat, likely due to elevated valuation (28.71 PE ratio), modest revenue growth (0.72% beat), and broader market selling pressure. The stock has declined 4.58% over five days, suggesting profit-taking and valuation concerns.
What is Meyka AI’s rating for Xylem?
Meyka AI rates XYL with a B+ grade, indicating neutral positioning. The company scores well on asset returns and DCF valuation but faces concerns on debt levels and PE valuation. The rating reflects balanced fundamentals with mixed growth signals.
What are the key concerns for Xylem investors?
Main concerns include elevated PE ratio of 28.71, declining operating cash flow (-1.74% YoY), and falling free cash flow (-3.40% YoY). Stock trades at premium valuations with modest revenue growth, raising questions about sustainability at current prices.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)